Glial cell‐dominated inflammatory microenvironment and neuronal damage due to oxidative
stress are major impediments to the treatment of central nervous degenerative diseases …

Neuroinflammation is associated with a series of pathological symptoms in Parkinson's
disease (PD), including α‐synuclein aggregation and dopaminergic neuronal death. The …

Nanomedicine-based anti-neuroinflammation strategy has become a promising dawn of
Parkinson's disease (PD) treatment. However, there are significant gaps in our …

Parkinson's disease (PD) is a complex neurodegenerative disease affected by many factors.
Although there are treatments to combat the symptoms of PD, such as levodopa and deep …

Parkinson's disease (PD) is the second most common neurodegenerative disease globally,
and there is currently no effective treatment for this condition. Excessive accumulation of …

Parkinson's disease (PD), as the second most common neurodegenerative disease after
Alzheimer's, has become intractable with the increasing aging global population. The …

The entangled dynamic circulation between β-amyloid (Aβ) and neuroinflammation is the
main reason for the failure of monotherapy in Alzheimer's disease (AD) at present …

Inflammation and neuroinflammation play critical roles in the pathogenesis of
neurodegenerative diseases such as Parkinson's disease (PD). Nanomaterials with reactive …

Oxidative stress is always mentioned as a pathologic appearance of Alzheimer's disease
(AD). It is attributed to mitochondrial dysfunction closely linked to Aβ deposition and …

Microglia as an important type of innate immune cell in the brain have been considered as
an effective therapeutic target for the treatment of central nervous degenerative diseases …